News CYGNOS BioTech, LLC Selected for U.S. Department of Defense SBIR Phase II Negotiation to Advance Broad-Spectrum Antiviral Platform January 5, 2026 by Walid Chaar
News CYGNOS BioTech to Present Innovative PVX Antiviral Platform at U.S. DoD and International Scientific Conference July 8, 2025 by Walid Chaar